Am J Transplant, Volume 19, Suppl 3 Archives - Page 135 of 214 - ATC Abstracts

2019 American Transplant Congress
Novel In Vitro Germinal Center Culture System Demonstrates More Aggressive B Cell to Plasma Blast Differentiation in Allosensitized Nonhuman Primates
P. Schroder, J. Yoon, R. Schmitz, Z. Fitch, J. Kwun, S. J. Knechtle
Department of Surgery, Duke University Medical Center, Durham, NC
*Purpose: The allogeneic humoral immune response is largely composed of T cell dependent antibody responses produced after B and T cells interact within the germinal…
2019 American Transplant Congress
The Association of Health Literacy with Physical and Mental Health-Related Quality of Life in Organ Transplant Candidates
K. Chapin¹, S. Rega¹, L. Dageforde², D. Moore¹, M. Via¹, I. D. Feurer¹
¹Vanderbilt Transplant Center, Vanderbilt University Medical Center, Nashville, TN, ²Transplant Surgery, Massachusetts General Hospital, Boston, MA
*Purpose: This study aimed to determine the association of health literacy with pre-transplant health-related quality of life (HRQOL) in adults evaluated for potential listing for…
2019 American Transplant Congress
Economic Evaluation of Kidney Transplantation in the Elderly Stratified by Donor Quality
M. Kadatz¹, S. Klarenbach², J. S. Gill¹, J. Gill¹
¹Nephrology, University of British Columbia, Vancouver, BC, Canada, ²Nephrology, University of Alberta, Edmonton, AB, Canada
*Purpose: The cost-effectiveness of kidney transplantation in the elderly in recipients of a kidney with a high kidney donor profile index (KDPI) is unknown. In…
2019 American Transplant Congress
Apixaban Therapy Is Safe And Effective In Most Organ Transplant Populations
A. Brown, S. Palkimas, W. Ally
University of Virginia Health System, Charlottesville, VA
*Purpose: The bleed rates from the apixaban pivotal trial were 12.1% for non-major and 3.8% major bleeds. However outcomes in transplant recipients are less defined,…
2019 American Transplant Congress
Identifying the Proverbial “Needle in the Arm” with Natural Language Processing
G. R. Vece, J. Foutz, A. Placona
Department of Research, United Network for Organ Sharing, Richmond, VA
*Purpose: Donors with a history of IVDU are associated with increased disease transmission risk; However, OPTN forms only request broad historical details relating to donor…
2019 American Transplant Congress
Impact of DAA Treatment on Graft Fibrosis in HCV Positive Liver Transplantation
J. Wellington¹, A. Ma², S. Kottilil³, J. Husson³, E. Wilson³, D. Bruno⁴
¹Gastroenterology & Hepatology, University of Maryland, Baltimore, MD, ²Internal Medicine, University of Maryland, Baltimore, MD, ³Institute of Human Virology, Division of Clinical Care and Research, University of Maryland, Baltimore, MD, ⁴Transplant Surgery, University of Maryland, Baltimore, MD
*Purpose: Liver transplantation, LT, for HCV-related disease has the lowest five-year graft survival of all LT recipients, primarily due to accelerated fibrosis from unrestrained HCV…
2019 American Transplant Congress
Comprehensive and Combined Transcriptomic and Proteomic Analysis Reveals Key Factors Underlying Ischemia-Reperfusion Injury in Human Liver Transplantation
S. Huang, X. He, C. Sun, Z. Guo, W. Ju, Z. Zhu, Q. Zhao, G. Chen
Organ Transplant Center, the First Affiliated Hospital of SYSU, Guangzhou, China
*Purpose: Ischemia-reperfusion injury (IRI) is a major challenge in liver resection and liver transplantation surgery. Hepatic IRI can seriously impair liver function and even cause…
2019 American Transplant Congress
Impact of Transplant Surgery Advanced Practice Providers in the Management of Pancreas Transplant Recipients
E. A. Herriman, J. M. Sharp, K. J. Brown, J. R. Montgomery, J. C. Magee, J. D. Punch, R. S. Sung, K. J. Woodside
Section of Transplantation, Department of Surgery, University of Michigan, Ann Arbor, MI
*Purpose: Transplant surgery advanced practice providers (APPs) roles and responsibilities vary widely between different transplant centers. In an effort to standardize care for the pancreas…
2019 American Transplant Congress
The Need for Diabetic Medications after Pancreas Transplantation
A. Bhansali, O. El Shamy, M. Menon, R. Shapiro, V. Delaney, G. De Boccardo
Mount Sinai Hospital, New York, NY
*Purpose: Patients with diabetes mellitus can experience microvascular complications resulting in end organ damage ultimately necessitating pancreatic transplantation. While there is well documented improvement in…
2019 American Transplant Congress
Exercise for Solid Organ Transplant Candidates and Recipients: A Joint Position Statement of the Canadian Society of Transplantation (CST) and Canadian Network for Rehabilitation and Exercise for Solid Organ Transplant Optimal Recovery (CAN-RESTORE)
T. Janaudis-Ferreira¹, S. Mathur², R. Deliva³, N. Howes⁴, C. Patterson⁵, A. Räkel⁶, S. So⁵, L. Wickerson⁷, M. White⁶, Y. Avitzur⁵, O. Johnston⁸, N. Heywood⁹, S. Singh⁷, S. Holdsworth¹⁰
¹School of Physical and Occupational Therapy, McGill University, Montreal, QC, Canada, ²University of Toronto, Toronto, ON, Canada, ³The Hospital for Sick Children, Toronto, ON, Canada, ⁴London Health Sciences Centre, London, ON, Canada, ⁵The Hospital For Sick Children, Toronto, ON, Canada, ⁶University of Montreal Hospital Centre, Montreal, QC, Canada, ⁷University Health Network, Toronto, ON, Canada, ⁸Vancouver General Hospital, Vancouver, BC, Canada, ⁹McGill University Health Centre, Montreal, QC, Canada, ¹⁰Canadian Donation and Transplantation Research Program, Edmonton, AB, Canada
*Purpose: Exercise training has been shown to be beneficial across several chronic disease groups that may lead to solid organ transplantation (SOT), and across organ…